U.S., March 17 -- ClinicalTrials.gov registry received information related to the study (NCT07472387) titled 'Impact of Androgen Signaling on the Composition of the Immune Microenvironment in Glioblastomas' on Feb. 16.
Brief Summary: Glioblastoma (GBM) is the most common and most aggressive primary brain cancer in adults. GBM is more common in men than in women, with a male-to-female ratio of 1.6. Furthermore, being male is associated with a poorer prognosis. These data suggest that sex and/or sexual hormones and more specifically androgens may play a role in the initiation, the growth, and the resistance to treatments of GBM.
Study Start Date: April 01
Study Type: INTERVENTIONAL
Condition:
Glioblastoma (GBM)
Intervention:
OTHER: blo...